# Immune Cells Phenotypes During COVID-19

> **NCT04816760** · — · UNKNOWN · sponsor: **Institut Hospitalo-Universitaire Méditerranée Infection** · enrollment: 100 (estimated)

## Conditions studied

- Sars-CoV2
- Innate Immunity
- Immunization; Infection
- Alveolar Lung Disease
- Endothelial Dysfunction

## Interventions

- **BIOLOGICAL:** Peripheral blood samples

## Key facts

- **NCT ID:** NCT04816760
- **Lead sponsor:** Institut Hospitalo-Universitaire Méditerranée Infection
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-25
- **Primary completion:** 2021-06
- **Final completion:** 2021-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04816760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04816760, "Immune Cells Phenotypes During COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04816760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*